Tarsus Pharmaceuticals (TARS) Profit After Tax: 2020-2025
Historic Profit After Tax for Tarsus Pharmaceuticals (TARS) over the last 6 years, with Sep 2025 value amounting to -$12.6 million.
- Tarsus Pharmaceuticals' Profit After Tax rose 46.26% to -$12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$81.2 million, marking a year-over-year increase of 39.59%. This contributed to the annual value of -$115.6 million for FY2024, which is 14.97% up from last year.
- Per Tarsus Pharmaceuticals' latest filing, its Profit After Tax stood at -$12.6 million for Q3 2025, which was up 38.13% from -$20.3 million recorded in Q2 2025.
- Over the past 5 years, Tarsus Pharmaceuticals' Profit After Tax peaked at $10.4 million during Q1 2021, and registered a low of -$41.9 million during Q4 2023.
- Moreover, its 3-year median value for Profit After Tax was -$25.1 million (2025), whereas its average is -$28.1 million.
- In the last 5 years, Tarsus Pharmaceuticals' Profit After Tax spiked by 630.20% in 2021 and then tumbled by 447.17% in 2023.
- Quarterly analysis of 5 years shows Tarsus Pharmaceuticals' Profit After Tax stood at -$14.9 million in 2021, then rose by 8.43% to -$13.6 million in 2022, then crashed by 208.13% to -$41.9 million in 2023, then soared by 44.84% to -$23.1 million in 2024, then surged by 46.26% to -$12.6 million in 2025.
- Its Profit After Tax stands at -$12.6 million for Q3 2025, versus -$20.3 million for Q2 2025 and -$25.1 million for Q1 2025.